Home » Stocks » Tandem Diabetes Care

Tandem Diabetes Care, Inc. (TNDM)

Stock Price: $95.43 USD -4.85 (-4.84%)
Updated Aug 11, 2020 4:00 PM EDT - Market closed
After-hours: $95.40 -0.03 (-0.03%) Aug 11, 4:10 PM

Stock Price Chart

Key Info

Market Cap 5.81B
Revenue (ttm) 410.22M
Net Income (ttm) -42.22M
Shares Out 60.91M
EPS (ttm) -0.71
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 11, 2020
Last Price $95.43
Previous Close $100.28
Change ($) -4.85
Change (%) -4.84%
Day's Open 99.38
Day's Range 94.00 - 99.38
Day's Volume 1,608,154
52-Week Range 43.69 - 110.80

More Stats

Market Cap 5.81B
Enterprise Value 5.61B
Earnings Date (est) Oct 29, 2020
Ex-Dividend Date n/a
Shares Outstanding 60.91M
Float 59.15M
EPS (basic) -0.7
EPS (diluted) -0.71
FCF / Share 0.16
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield 0.16%
Payout Ratio n/a
Shares Short 3.80M
Short Ratio 2.20
Short % of Float 6.65%
Beta 0.55
PE Ratio n/a
Forward PE n/a
P/FCF Ratio 618.00
PS Ratio 14.17
PB Ratio 24.00
Revenue 410.22M
Operating Income -29.47M
Net Income -42.22M
Free Cash Flow 9.41M
Net Cash 204.00M
Net Cash / Share 3.35
Gross Margin 47.34%
Operating Margin -7.18%
Profit Margin -10.30%
FCF Margin 2.29%
ROA -4.23%
ROE -20.45%
ROIC -15.40%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (14)

Buy 9
Overweight 1
Hold 4
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(25.53% upside)
Current: $95.43
Target: 119.79
*Average 12-month price target from 14 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth97.05%70.88%27.72%15.65%46.51%71.41%1072%--
Gross Profit19489.8244.0923.5926.5815.256.17-1.35-
Operating Income-16.72-44.63-62.94-78.05-69.00-75.66-49.43-33.05-24.21
Net Income-24.75-123-73.03-83.45-72.42-79.52-63.14-33.02-25.51
Shares Outstanding58.5148.135.683.062.892.330.290.020.02
Earnings Per Share-0.42-2.55-12.87-27.30-25.04-34.17-214.60-1,758.80-1,498.70
Operating Cash Flow41.91-8.32-66.14-61.17-58.76-61.38-47.76-33.47-21.55
Capital Expenditures-19.54-2.99-5.72-8.93-5.76-4.41-4.01-4.53-1.32
Free Cash Flow22.36-11.31-71.85-70.10-64.53-65.78-51.77-38.00-22.87
Cash & Equivalents17612914.1855.5473.1169.2813217.210.00
Total Debt20.38-76.5478.9629.2829.4429.404.20-
Net Cash / Debt156129-62.36-23.4243.8339.8410213.010.00
Book Value195131-29.15-5.9363.4754.57116-106-
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Tandem Diabetes Care, Inc.
Country United States
Employees 1,043
CEO John F. Sheridan

Stock Information

Ticker Symbol TNDM
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: TNDM
IPO Date November 14, 2013


Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin delivery system with Basal-IQ Technology; t:slim X2 with control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump and supported blood glucose meters for users, their caregivers, and their healthcare providers. Its products in development include t:sport insulin delivery system; and connected (mobile) health offerings. Further, the company offers Sugarmate, a mobile app for people with diabetes who use insulin. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was founded in 2006 and is headquartered in San Diego, California.